Academic Research Library

Find some of the best Journals and Proceedings.

PD-L1 and FOXP3 Expression in De Novo Invasive Breast Carcinoma: Association with Molecular Subtypes and Clinicopathological Parameters

Author : Dr. Thaarini P, Dr. Ashish Kumar Gupta, Dr. Rahul Satarkar, Dr. Radhakrishna Ramchandani, Dr. Amit Kumar

Abstract : Background: The tumour immune microenvironment plays an important role in breast carcinoma progression and immune evasion. Programmed cell death-ligand 1 (PD-L1) and Forkhead box protein 3 (FOXP3)-positive regulatory T cells are key components of tumour-associated immune suppression. Their combined evaluation may provide insight into the immunological heterogeneity of invasive breast carcinoma. Aim: To evaluate PD-L1 and FOXP3 expression by immunohistochemistry in de novo invasive breast carcinoma and assess their association with molecular subtypes and clinicopathological parameters. Methods: This cross-sectional study included 97 women with de novo invasive breast carcinoma. PD-L1 expression was assessed using combined positive score (CPS), tumour proportion score (TPS), and immune-cell score, while FOXP3 expression was evaluated in tumour-infiltrating lymphocytes. Associations were analysed using appropriate statistical tests, with Spearman’s rank correlation for PD-L1 and FOXP3 scores. Results: PD-L1 CPS ≥1 was observed in 65.98% of cases versus TPS ≥1 in 35.05%. CPS positivity was significantly associated with higher histological grade (p<0.0001), estrogen receptor negativity (p=0.0028), progesterone receptor negativity (p=0.0005), and triple-negative breast cancer (p=0.0414); Luminal A tumours showed significantly lower CPS expression (p=0.0025). High FOXP3 expression was observed in 16.49% and was associated with histological grade (p=0.0289) and nodal status (p=0.0017). Notably, all high-FOXP3 tumours were CPS-positive (p=0.0043). FOXP3 correlated with CPS (ρ=0.43) and more strongly with PD-L1 immune-cell score (ρ=0.49), both p<0.0001. Conclusion: PD-L1 and FOXP3 are closely associated within the breast tumour immune microenvironment, particularly within the immune-cell compartment, suggesting a coordinated immunosuppressive profile. PD-L1 was preferentially associated with higher grade, hormone-receptor-poor tumours, particularly triple-negative breast cancer. Combined assessment of these markers may provide more comprehensive immune profiling of invasive breast carcinoma.

Keywords : PD-L1, foxp3, cps, invasive breast carcinoma, tumour immune microenvironment, immunohistochemistry.

Conference Name : International Conference on Cancer Pathology (ICCPATH - 26)

Conference Place : Hyderabad, India

Conference Date : 18th Oct 2026

Preview